These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 36483910)

  • 1. Comparative highlights on MERS-CoV, SARS-CoV-1, SARS-CoV-2, and NEO-CoV.
    Goyal R; Gautam RK; Chopra H; Dubey AK; Singla RK; Rayan RA; Kamal MA
    EXCLI J; 2022; 21():1245-1272. PubMed ID: 36483910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion.
    Coleman CM; Sisk JM; Mingo RM; Nelson EA; White JM; Frieman MB
    J Virol; 2016 Oct; 90(19):8924-33. PubMed ID: 27466418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
    Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
    Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From SARS coronavirus to novel animal and human coronaviruses.
    To KK; Hung IF; Chan JF; Yuen KY
    J Thorac Dis; 2013 Aug; 5 Suppl 2(Suppl 2):S103-8. PubMed ID: 23977429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility to SARS, MERS, and COVID-19 from animal health perspective.
    Gautam A; Kaphle K; Shrestha B; Phuyal S
    Open Vet J; 2020 Aug; 10(2):164-177. PubMed ID: 32821661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).].
    Lvov DK; Alkhovsky SV
    Vopr Virusol; 2020; 65(2):62-70. PubMed ID: 32515561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lethal zoonotic coronavirus infections of humans - comparative phylogenetics, epidemiology, transmission, and clinical features of coronavirus disease 2019, The Middle East respiratory syndrome and severe acute respiratory syndrome.
    Hui DS; Zumla A; Tang JW
    Curr Opin Pulm Med; 2021 May; 27(3):146-154. PubMed ID: 33660619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Basis of Pathogenesis of Coronaviruses: A Comparative Genomics Approach to Planetary Health to Prevent Zoonotic Outbreaks in the 21st Century.
    Asrani P; Hasan GM; Sohal SS; Hassan MI
    OMICS; 2020 Nov; 24(11):634-644. PubMed ID: 32940573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative review of pathogenesis and host innate immunity evasion strategies among the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV).
    Noor R
    Arch Microbiol; 2021 Jul; 203(5):1943-1951. PubMed ID: 33682075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past.
    Shah VK; Firmal P; Alam A; Ganguly D; Chattopadhyay S
    Front Immunol; 2020; 11():1949. PubMed ID: 32849654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection.
    Liang Y; Wang ML; Chien CS; Yarmishyn AA; Yang YP; Lai WY; Luo YH; Lin YT; Chen YJ; Chang PC; Chiou SH
    Front Immunol; 2020; 11():1022. PubMed ID: 32574260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging SARS-CoV, MERS-CoV, and SARS-CoV-2: An insight into the viruses zoonotic aspects.
    Al-Salihi KA; Khalaf JM
    Vet World; 2021 Jan; 14(1):190-199. PubMed ID: 33642804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2.
    Signer J; Jonsdottir HR; Albrich WC; Strasser M; Züst R; Ryter S; Ackermann-Gäumann R; Lenz N; Siegrist D; Suter A; Schoop R; Engler OB
    Virol J; 2020 Sep; 17(1):136. PubMed ID: 32907596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses.
    Zhu Z; Lian X; Su X; Wu W; Marraro GA; Zeng Y
    Respir Res; 2020 Aug; 21(1):224. PubMed ID: 32854739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Strategies of Antiviral Drug Discovery for COVID-19.
    Mei M; Tan X
    Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Broad-spectrum coronavirus antiviral drug discovery.
    Totura AL; Bavari S
    Expert Opin Drug Discov; 2019 Apr; 14(4):397-412. PubMed ID: 30849247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of animal models against emerging coronaviruses: From SARS to MERS coronavirus.
    Sutton TC; Subbarao K
    Virology; 2015 May; 479-480():247-58. PubMed ID: 25791336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioactive natural compounds against human coronaviruses: a review and perspective.
    Xian Y; Zhang J; Bian Z; Zhou H; Zhang Z; Lin Z; Xu H
    Acta Pharm Sin B; 2020 Jul; 10(7):1163-1174. PubMed ID: 32834947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS.
    Drexler JF; Corman VM; Drosten C
    Antiviral Res; 2014 Jan; 101():45-56. PubMed ID: 24184128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.